Mammalian Microsomal Cytochrome P450 Monooxygenase

Williams, Pamela A., Cosme, Jose, Sridhar, Vandana, Johnson, Eric F., McRee, Duncan E.·2000·Molecular Cell

Cited by (707)

Items 401–500 of 707

  1. Differences in flexibility of active sites of cytochromes P450 probed by resonance Raman and UV–Vis absorption spectroscopy
    Pavel Anzenbacher, Jiřı́ Hudeček · 2001 · Journal of Inorganic Biochemistry
  2. Quantitative structure–activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes
    David F.V. Lewis · 2003 · Toxicology in Vitro
  3. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling
    Samuel L. Collom, Arvind P. Jamakhandi, Alan J. Tackett, Anna Radominska-p, Grover Paul Miller · 2006 · Archives of Biochemistry and Biophysics
  4. Structural Determinants of Aromatase Cytochrome P450 Inhibition in Substrate Recognition Site-1
    Alan James Conley, Samantha M. Mapes, C. Jo Corbin, Douglas Greger, Sandra E. Graham · 2002 · Molecular Endocrinology
  5. Interaction of New Sulfaphenazole Derivatives with Human Liver Cytochrome P450 2Cs: Structural Determinants Required for Selective Recognition by CYP 2C9 and for Inhibition of Human CYP 2Cs
    Nguyêt-Thanh Ha Duong, Cristina Marques‐Soares, Sylvie Dijols, Marie‐Agnès Sari, Patrick M. Dansette, Daniel Mansuy · 2001 · Archives of Biochemistry and Biophysics
  6. Functional analysis of CYP2D6.31 variant: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution
    Delphine Allorge, Didier Bréant, Jacky HARLOW, Joey Chowdry, Jean‐Marc Lo‐Guidice, Dany Chevalier, Christelle Cauffiez, Michel Lhermitte, Frank E. Blaney, Geoffrey T. Tucker et al. · 2005 · Proteins Structure Function and Bioinformatics
  7. Generation of 2,3,7,8-TCDD-metabolizing enzyme by modifying rat CYP1A1 through site-directed mutagenesis
    Raku Shinkyo, Toshiyuki Sakaki, Teisuke Takita, Miho Ohta, Kuniyo Inouye · 2003 · Biochemical and Biophysical Research Communications
  8. CYP21 mutations in simple virilizing congenital adrenal hyperplasia
    Svetlana Lajić, Tiina Robins, Nils Peter Krone, Hans P. Schwarz, Anna Wedell · 2001 · Journal of Molecular Medicine
  9. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template
    David F.V. Lewis · 2002 · Journal of Inorganic Biochemistry
  10. Cytochrome P450 1A1-mediated anticancer drug discovery:in silicofindings
    Prajwal Prabhakarrao Nandekar, Abhay T. Sangamwar · 2012 · Expert Opinion on Drug Discovery
  11. On the application of the MARTINI coarse-grained model to immersion of a protein in a phospholipid bilayer
    Ghulam Mustafa, Prajwal Prabhakarrao Nandekar, Xiaofeng Yu, Rebecca C. Wade · 2015 · The Journal of Chemical Physics
  12. Cytochrome P450 side-chain cleavage: Insights gained from homology modeling
    Karl‐Heinz Storbeck, Pieter Swart, Amanda Cecilia Swart · 2007 · Molecular and Cellular Endocrinology
  13. Cytochrome P-450-CO and substrates: lessons from ligand binding under high pressure
    Christiane Jung · 2002 · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
  14. The cytochrome P450BM-1 of Bacillus megaterium A14K is induced by 2,3,7,8-Tetrachlorinated dibenzo-p-dioxin: Biophysical, molecular and biochemical determinants
    Abdulsamie Hanano, Mouhnad Shaban, Douaa Almutlk, Ibrahem Almousally · 2018 · Chemosphere
  15. Structure–function relationships of rat liver CYP3A9 to its human liver orthologs: site-directed active site mutagenesis to a progesterone dihydroxylase
    Linlong Xue, Victor Gavrilovich Zgoda, Byron H. Arison, Maria Almira Correia · 2002 · Archives of Biochemistry and Biophysics
  16. The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions
    Ji Won Park, James Robert Reed, Wayne L. Backes · 2015 · Journal of Biological Chemistry
  17. Not All Amino Acid Substitutions of the Common Cluster E6 Mutation inCYP21Cause Congenital Adrenal Hyperplasia
    Tiina Robins, Michela Barbaro, Svetlana Lajić, Anna Wedell · 2005 · The Journal of Clinical Endocrinology & Metabolism
  18. JUD COON: 35 YEARS OF P450 RESEARCH, A SYNOPSIS OF P450 HISTORY
    Todd D. Porter · 2004 · Drug Metabolism and Disposition
  19. Do Drug Metabolism and Pharmacokinetic Departments Make Any Contribution to Drug Discovery?
    Dennis A. Smith, Esther F. Schmid, Barry Jones · 2002 · Clinical Pharmacokinetics
  20. Association of Cytochrome P450 Enzymes is a Determining Factor in their Catalytic Activity
    Eszter Hazai, Zsolt Bikádi, Miklós Simonyi, David Kupfer · 2005 · Journal of Computer-Aided Molecular Design
  21. Sequence alignments, variabilities, and vagaries
    Sandra E. Graham, Julian A. Peterson · 2002 · Methods in enzymology on CD-ROM/Methods in enzymology
  22. Discovery of the Biosynthetic Pathway of Beticolin 1 Reveals a Novel Non‐Heme Iron‐Dependent Oxygenase for Anthraquinone Ring Cleavage
    Xiaodong Hou, Huibin Xu, Zhiwei Deng, Yijun Yan, Zhenbo Yuan, Xuanzhong Liu, Zengping Su, Sai Yang, Yan Zhang, Yijian Rao · 2022 · Angewandte Chemie International Edition
  23. Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase
    Natalia Mast, Wei-Li Liao, Irina A. Pikuleva, Illarion V. Turko · 2009 · Archives of Biochemistry and Biophysics
  24. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
    Nadhir Litim, Marc Morissette, Donatella Caruso, Roberto Cosimo Melcangi, Thérèse Di Paolo · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
  25. Langmuir–Blodgett nanotemplates for protein crystallography
    Eugenia Pechkova, Claudio Ando Nicolini · 2017 · Nature Protocols
  26. Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4
    David F. V. Lewis, Brian G. Lake, Maurice Dickins · 2004 · Xenobiotica
  27. TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
    Yoshitaka Yamaguchi, Kishore Kumar Khan, You Ai He, You He, James R. Halpert · 2004 · Drug Metabolism and Disposition
  28. In silico description of differential enantioselectivity in methoxychlor O-demethylation by CYP2C enzymes
    Zsolt Bikádi, Eszter Hazai · 2008 · Biochimica et Biophysica Acta (BBA) - General Subjects
  29. Characterization of Medicago truncatula (barrel medic) hydroperoxide lyase (CYP74C3), a water-soluble detergent-free cytochrome P450 monomer whose biological activity is defined by monomer–micelle association
    Richard K. Hughes, Eric J. Belfield, Mylrajan Muthusamay, Anuja Khan, Arthur J. Rowe, Stephen E. Harding, Shirley A. Fairhurst, Stephen Bornemann, Ruth A. Ashton, Roger N. F. THORNELEY et al. · 2006 · Biochemical Journal
  30. N-Terminal Deletions and His-Tag Fusions Dramatically Affect Expression of Cytochrome P450 2C2 in Bacteria
    Balraj Doray, Ci-Di Chen, BYRON W. KEMPER · 2001 · Archives of Biochemistry and Biophysics
  31. A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series
    Roy J. Vaz, Akbar Nayeem, Kenneth S. Santone, Gamini Chandrasena, Ashvinikumar V. Gavai · 2005 · Bioorganic & Medicinal Chemistry Letters
  32. An epoxidation mechanism of carbamazepine by CYP3A4
    Masayuki Hata, Yoshikazu Tanaka, Naoko Kyoda, Taisuke Osakabe, Hitomi Yuki, Itsuko Ishii, Mitsukazu Kitada, Saburo Neya, Tyuji Hoshino · 2008 · Bioorganic & Medicinal Chemistry
  33. Scalable production and application of Pichia pastoris whole cell catalysts expressing human cytochrome P450 2C9
    Javier Garrigós‐Martínez, Astrid Weninger, José Luis González Montesinos, Christian Schmid, Francisco Valero, Claudia Rinnofner, Anton Glieder, Xavier Garcia‐Ortega · 2021 · Microbial Cell Factories
  34. Lipophilicity Relationships in Inhibitors of CYP2C9 and CYP2C19 Enzymes
    David F.V. Lewis, Brian G. Lake, Yuko Ito, Maurice Dickins · 2006 · Journal of Enzyme Inhibition and Medicinal Chemistry
  35. De-bugging and maximizing plant cytochrome P450 production in Escherichia coli with C-terminal GFP fusions
    Ulla Christensen, Darío Martínez Vázquez, Karina Marie Søgaard, Tonja Hobel, Morten Thrane Nielsen, Scott James Harrison, Anders Holmgaard Hansen, Birger Lindberg Møller, Susanna Seppälä, Morten H. H. Nørholm · 2017 · Applied Microbiology and Biotechnology
  36. Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations
    Chris de Graaf, Chris Oostenbrink, Peter H. J. Keizers, Barbara M. A. van Vugt‐Lussenburg, Jan N. M. Commandeur, Nico P.E. Vermeulen · 2007 · European Biophysics Journal
  37. Biocatalysis and substrate chemodiversity: Adaptation of aerobic living organisms to their chemical environment
    Daniel Mansuy · 2008 · Catalysis Today
  38. Evolution of drug metabolism: Hitchhiking the technology bandwagon
    John O. Miners · 2002 · Clinical and Experimental Pharmacology and Physiology
  39. Modelling Human Cytochromes P450 for Evaluating Drug Metabolism: An Update
    David F. V. Lewis · 2000 · Drug metabolism and drug interactions
  40. Site-Directed Mutagenesis of Cytochrome P450eryF: Implications for Substrate Oxidation, Cooperativity, and Topology of the Active Site
    Kishore Kumar Khan, You Ai He, You He, James R. Halpert · 2002 · Chemical Research in Toxicology
  41. A comparative approach to structure–function studies of mammalian aromatases
    Alan James Conley, Samantha M. Mapes, C. Jo Corbin, D.L. Greger, Karen M. Walters, John M. Trant, Sandra E. Graham · 2001 · The Journal of Steroid Biochemistry and Molecular Biology
  42. Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis
    Philip David Josephy · 2002 · Toxicology
  43. The genome sequence ofMycobacterium tuberculosis reveals cytochromes P450 as novel anti-TB drug targets
    Alison Souter, Kirsty J. McLean, W. Ewen Smith, Andrew W. Munro · 2000 · Journal of Chemical Technology & Biotechnology
  44. Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions
    D. F. V. Lewis, Brian G. Lake, Maurice Dickins, Peter S. Goldfarb · 2004 · Xenobiotica
  45. STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES
    Lovisa Afzelius, Florian Raubacher, Anders Karlén, Flemming Steen Jørgensen, Tommy B. Andersson, Collen Mutowembwa Masimirembwa, Ismael Zamora · 2004 · Drug Metabolism and Disposition
  46. Phylogenomic Analysis of Cytochrome P450 Gene Superfamily and Their Association with Flavonoids Biosynthesis in Peanut (Arachis hypogaea L.)
    Kun Zhang, Yong-Mei Qin, Wei Sun, Hourui Shi, Shuzhen Zhao, Liangqiong He, Changsheng Li, Jin Zhao, Jiaowen Pan, Guanghao Wang et al. · 2023 · Genes
  47. Studies of Binding Modes of (S)-Mephenytoin to Wild Types and Mutants of Cytochrome P450 2C19 and 2C9 Using Homology Modeling and Computational Docking
    Akifumi Oda, Noriyuki Yamaotsu, Shuichi Hirono · 2004 · Pharmaceutical Research
  48. Important Amino Acid Residues that Confer CYP2C19 Selective Activity to CYP2C9
    Yoh Wada, M. Mitsuda, Yasuhiro Ishihara, Masashi Watanabe, M. Iwasaki, S. Asahi · 2008 · The Journal of Biochemistry
  49. Protein Engineering of the Cytochrome P450 Monooxygenase from Bacillus megaterium
    Vlada B. Urlacher, Rolf Dieter Schmid · 2004 · Methods in enzymology on CD-ROM/Methods in enzymology
  50. Directed Evolution Reveals Requisite Sequence Elements in the Functional Expression of P450 2F1 inEscherichia coli
    James B. Y. H. Behrendorff, Chad D. Moore, Keon-Hee Kim, Dae‐Hwan Kim, Christopher A. Smith, Wayne A. Johnston, Chul‐Ho Yun, Garold S. Yost, Elizabeth M. J. Gillam · 2012 · Chemical Research in Toxicology
  51. Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme
    Cynthia E. Hernandez, Santosh Kumar, Hong Shu Liu, James R. Halpert · 2006 · Archives of Biochemistry and Biophysics
  52. Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme–substrate interactions and QSARs for binding affinity and inhibition
    D.F.V. Lewis, Brian G. Lake, Maurice Dickins, Peter S. Goldfarb · 2003 · Toxicology in Vitro
  53. Sulfaphenazole Derivatives as Tools for Comparing Cytochrome P450 2C5 and Human Cytochromes P450 2Cs: Identification of a New High Affinity Substrate Common to Those Enzymes
    Cristina Marques‐Soares, Sylvie Dijols, Anne‐Christine Macherey, Michael R. Wester, Eric F. Johnson, Patrick M. Dansette, Daniel Mansuy · 2003 · Biochemistry
  54. Structural Similarities and Differences of the Heme Pockets of Various P450 Isoforms as Revealed by Resonance Raman Spectroscopy
    Jiřı́ Hudeček, Eva Anzenbacherová, Pavel Anzenbacher, Andrew W. Munro, Peter Hildebrandt · 2000 · Archives of Biochemistry and Biophysics
  55. Identification and Analysis of Conserved Sequence Motifs in Cytochrome P450 Family 2
    Numan Oezguen, Santosh Kumar, Aditya Hindupur, Werner A. Braun, Bilikallahalli K. Muralidhara, James R. Halpert · 2008 · Journal of Biological Chemistry
  56. Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome b 5 and Cytochrome c
    Katherine A. Gentry, Elke Prade, Carlo Barnaba, Meng Zhang, Mukesh K. Mahajan, Sang‐Choul Im, Gattadahalli M. Anantharamaiah, Satoshi Nagao, Lucy A. Waskell, Ayyalusamy Ramamoorthy · 2017 · Scientific Reports
  57. A Virtual Screening Filter for Identification of Cytochrome P450 2C9 (CYP2C9) Inhibitors
    Evgeny Byvatov, Karl H. Baringhaus, Gisbert Schneider, Hans Matter · 2006 · QSAR & Combinatorial Science
  58. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity
    Martiniano Bello, Jessica Elena Mendieta‐Wejebe, José Correa‐Basurto · 2014 · Biochemical Pharmacology
  59. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1
    R. Foti, Nina Isoherranen, Alex Zelter, Leslie J. Dickmann, Brian Buttrick, Philippe Diaz, Dominique Douguet · 2016 · Journal of Pharmacology and Experimental Therapeutics
  60. Studies of Membrane Topology of Mitochondrial Cholesterol Hydroxylases CYPs 27A1 and 11A1
    Irina A. Pikuleva, Natalia Mast, Wei‐Li Liao, Illarion V. Turko · 2008 · Lipids
  61. Use of Molecular Simulation for Mapping Conformational CYP2E1 Epitopes
    Matteo Vidali, Mats Hidestrand, Erik Eliasson, Elisa Mottaran, Emanuela Reale, Roberta Rolla, Giuseppa Occhino, Emanuele Albano, Magnus Ingelman‐Sundberg · 2004 · Journal of Biological Chemistry
  62. Cloning and expression of two novel pig liver and kidney fatty acid hydroxylases [cytochrome P450 (CYP)4A24 and CYP4A25]
    Kerstin Lundell · 2002 · Biochemical Journal
  63. Probing sesquiterpene hydroxylase activities in a coupled assay with terpene synthases
    Bryan T. Greenhagen, Paul Griggs, Shunji Takahashi, Lyle Ralston, Joe Chappell · 2002 · Archives of Biochemistry and Biophysics
  64. Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population
    Sirkku T. Saarikoski, Tuula Suitiala, Reetta J. Holmila, Olli Impivaara, Jorma O. Järvisalo, Ari Hirvonen, Kirsti Husgafvel‐Pursiainen · 2004 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  65. Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points
    Hindupur K. Anandatheerthavarada, Govindasamy Amuthan, Gopa Biswas, Marie‐Anne Robin, Ramachandran Murali, Michael R. Waterman, Narayan G. Avadhani · 2001 · The EMBO Journal
  66. THE STRUCTURE OF MICROSOMAL CYTOCHROME P450 2C5: A STEROID AND DRUG METABOLIZING ENZYME
    Eric F. Johnson, Michael R. Wester, Charles David Stout · 2002 · Endocrine Research
  67. AFM study of the interaction of cytochrome P450 2C9 with phospholipid bilayers
    Matthew R. Nussio, Nicolas Hans Voelcker, John O. Miners, Benjamin C. Lewis, Matthew J. Sykes, Joseph George Shapter · 2009 · Chemistry and Physics of Lipids
  68. Hepatic cytochrome P450 ubiquitination: Conformational phosphodegrons for E2/E3 recognition?
    Maria Almira Correia, Yongqiang Wang, Sung-Mi Kim, Shenheng Guan · 2014 · IUBMB Life
  69. Phanerochaete chrysosporium NADPH-cytochrome P450 reductase kinetic mechanism
    Andrew G. S. Warrilow, David C. Lamb, Diane E Kelly, Steven L. Kelly · 2002 · Biochemical and Biophysical Research Communications
  70. Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes
    Richard K. Hughes, Faridoon K. Yousafzai, Ruth A. Ashton, Ivan R. Chechetkin, Shirley A. Fairhurst, Mats Hámberg, Rod Casey · 2008 · Proteins Structure Function and Bioinformatics
  71. Structures of redox enzymes
    Andrew W. Munro, Paul Taylor, Malcolm D. Walkinshaw · 2000 · Current Opinion in Biotechnology
  72. Brief historical overview and recent progress on cytochromes P450: Adaptation of aerobic organisms to their chemical environment and new mechanisms of prodrug bioactivation
    Daniel Mansuy · 2010 · Annales Pharmaceutiques Françaises
  73. Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design.
    Sako Mirzaie, Latifeh Chupani, Ebrahim Barzegari, Ahmad Reza Shahverdi, Mostafa Jamalan · 2013 · EXCLI journal
  74. Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19
    Ghulam Mustafa, Prajwal Prabhakarrao Nandekar, Neil J. Bruce, Rebecca C. Wade · 2019 · International Journal of Molecular Sciences
  75. Effect of Cholesterol on the Interaction of Cytochrome P450 Substrate Drug Chlorzoxazone with the Phosphatidylcholine Bilayer
    Ayumi Yamada, Nobutaka Shimizu, Takaaki Hikima, Masaki Takata, Toshihide Kobayashi, Hiroshi Takahashi · 2016 · Biochemistry
  76. Coumarin 6, Hypericin, Resorufins, and Flavins: Suitable Chromophores for Fluorescence Correlation Spectroscopy of Biological Molecules
    Martin Beneš, Jiřı́ Hudeček, Pavel Anzenbacher, Martin Hof · 2001 · Collection of Czechoslovak Chemical Communications
  77. Thermodynamics of Ligand Binding to P450 2B4 and P450eryF Studied by Isothermal Titration Calorimetry
    Bilikallahalli K. Muralidhara, James R. Halpert · 2007 · Drug Metabolism Reviews
  78. CYP74C3 and CYP74A1, plant cytochrome P450 enzymes whose activity is regulated by detergent micelle association, and proposed new rules for the classification of CYP74 enzymes
    Richard K. Hughes, Eric J. Belfield, R. Casey · 2006 · Biochemical Society Transactions
  79. Explicit Water Near the Catalytic I Helix Thr in the Predicted Solution Structure of CYP2A4
    Anna Gorokhov, Masahiko Negishi, Eric F. Johnson, Lars Christian Pedersen, L. Perera, Tom Darden, Lee G. Pedersen · 2003 · Biophysical Journal
  80. Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells
    Nicholas E. Hadjokas, Renke Dai, Fred K. Friedman, Michael J. Spence, Barry J. Cusack, Robert E. Vestal, Yongsheng Ma · 2002 · British Journal of Pharmacology
  81. Arylacetamide κ opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity
    Bertrand Le Bourdonnec, Christopher W. Ajello, Pamela R. Seida, Roberta G. Susnow, Joel A. Cassel, Serge Belanger, Gabriel J. Stabley, Robert N. DeHaven, Diane L. DeHaven‐Hudkins, Roland E. Dolle · 2005 · Bioorganic & Medicinal Chemistry Letters
  82. Structural requirements for inhibitors of cytochromes P450 2B: Assessment of the enzyme interaction with diamondoids
    Petr Hodek, Lucie Bořek-Dohalská, Bruno Sopko, Miroslav Šulc, Stanislav Smrček, Jiřı́ Hudeček, Josef Janků, Marie Stiborová · 2005 · Journal of Enzyme Inhibition and Medicinal Chemistry
  83. Functional characterization of human cytochrome P450 2E1 allelic variants: in vitro metabolism of benzene and toluene by recombinant enzymes expressed in yeast cells
    Nobumitsu Hanioka, Maki Yamamoto, Toshiko Tanaka‐Kagawa, Hideto Jinno, Shizuo Narimatsu · 2009 · Archives of Toxicology
  84. Functional characterization of two novel CYP2C19 variants (CYP2C19*18andCYP2C19*19) found in a Japanese population
    Nobumitsu Hanioka, Nobumitsu Hanioka, Yumi Tsuneto, Y. Saito, T. Sumada, Keiko Maekawa, Keita Saito, Jun Sawada, S. Narimatsu · 2007 · Xenobiotica
  85. The ?-helical membrane spanning domain of cytochrome interacts with cytochrome P450 via nonspecific interactions
    Scott B. Mulrooney, D MEINHARDT, Lucy A. Waskell · 2004 · Biochimica et Biophysica Acta (BBA) - General Subjects
  86. Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency
    Jörg Bojunga, Christoph Welsch, Iris Antes, Mario Albrecht, Thomas Lengauer, Stefan Zeuzem · 2005 · Human Genetics
  87. Threonine-205 in the F Helix of P450 2B1 Contributes to Androgen 16β-Hydroxylation Activity and Mechanism-Based Inactivation
    Hsia-lien Lin, Haoming Zhang, Lucy A. Waskell, Paul F. Hollenberg · 2003 · Journal of Pharmacology and Experimental Therapeutics
  88. Incorporation of enzyme-mimic species in porous materials for the construction of porous biomimetic catalysts
    Zikun Liu, Jia‐Long Ling, Yangyang Liu, Bu-Hang Zheng, Chuan‐De Wu · 2024 · Chemical Communications
  89. Membrane integration of recombinant human P450 forms
    Alka Shukla, Wei‐Cheng Huang, Iris M. Booth Depaz, Elizabeth M. J. Gillam · 2009 · Xenobiotica
  90. Structure prediction and R115866 binding study of human CYP26A1: homology modelling, fold recognition, molecular docking and MD simulations
    Jinhong Ren, Xuqiong Xiong, Yu Sha, Maocai Yan, Bin Lin, Jinpan Wang, Yongkui Jing, Dongmei Zhao, M.S. Cheng · 2008 · Molecular Simulation
  91. π–π Stacking mediated drug–drug interactions in human CYP2E1
    Yue Liu, Bingya Liu, Pei Hao, Xuan Li, Yi‐Xue Li, Jingfang Wang · 2013 · Proteins Structure Function and Bioinformatics
  92. Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism
    Christopher D. Bostick, Katherine M. Hickey, Lance A. Wollenberg, Darcy R. Flora, Timothy S. Tracy, Peter M. Gannett · 2016 · Drug Metabolism and Disposition
  93. Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates
    Collen Mutowembwa Masimirembwa, Marianne Ridderström, Ismael Zamora, Tommy B. Andersson · 2002 · Methods in enzymology on CD-ROM/Methods in enzymology
  94. Toxicity study of allelochemical-like pesticides by a combination of 3D-QSAR, docking, Local Binding Energy (LBE) and GRID approaches
    F. Fratev, Elena Lo Piparo, Emilio Benfenati, Elina Mihaylova · 2007 · SAR and QSAR in environmental research
  95. Synthesis of Stereospecifically Deuterated 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) Diastereomers and Metabolism by A/J Mouse Lung Microsomes and Cytochrome P450 2A5
    John R. Jalas, Stephen S. Hecht · 2003 · Chemical Research in Toxicology
  96. Prediction of Drug-Like Molecular Properties
    Mehran Jalaie, Rieko Arimoto, Eric Gifford, Sabine Schefzick, Chris L. Waller · 2004 · Methods in molecular biology
  97. Biodegradation of dioxins by recombinant Escherichia coli expressing rat CYP1A1 or its mutant
    Raku Shinkyo, Masaki Kamakura, Shinichi Ikushiro, Kuniyo Inouye, Toshiyuki Sakaki · 2006 · Applied Microbiology and Biotechnology
  98. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
    C. Davies, Katey L. Witham, Justin R. Scott, Andrew Pearson, James J. De Voss, Sandra E. Graham, Elizabeth M. J. Gillam · 2004 · Drug Metabolism and Disposition
  99. Efficient Strategies for Lead Optimization by Simultaneously Addressing Affinity, Selectivity and Pharmacokinetic Parameters
    Karl H. Baringhaus, Hans Matter · 2007 · Wiley eBooks
  100. Exploring the Interactome of Cytochrome P450 2E1 in Human Liver Microsomes with Chemical Crosslinking Mass Spectrometry
    Dmitri R. Davydov, Bikash Dangi, Guihua Yue, Deepak Suresh Ahire, Bhagwat Prasad, Victor Gavrilovich Zgoda · 2022 · Biomolecules